| __timestamp | Dyne Therapeutics, Inc. | GSK plc |
|---|---|---|
| Wednesday, January 1, 2014 | 1145000000 | 7323000000 |
| Thursday, January 1, 2015 | 2028000000 | 8853000000 |
| Friday, January 1, 2016 | 2281000000 | 9290000000 |
| Sunday, January 1, 2017 | 2932000000 | 10342000000 |
| Monday, January 1, 2018 | 24000 | 10241000000 |
| Tuesday, January 1, 2019 | 271000 | 11863000000 |
| Wednesday, January 1, 2020 | 700000 | 11704000000 |
| Friday, January 1, 2021 | 1088000 | 11603000000 |
| Saturday, January 1, 2022 | 3345000 | 9554000000 |
| Sunday, January 1, 2023 | 2461000 | 8565000000 |
Unlocking the unknown
In the ever-evolving landscape of pharmaceuticals, understanding cost efficiency is crucial. GSK plc, a stalwart in the industry, and Dyne Therapeutics, Inc., a rising star, offer a fascinating comparison. From 2014 to 2023, GSK consistently maintained a high cost of revenue, peaking at approximately $11.9 billion in 2019. In contrast, Dyne Therapeutics experienced significant fluctuations, with a notable dip in 2018, where costs plummeted to just $24,000. This stark difference highlights GSK's stable yet high expenditure, while Dyne's variable costs suggest a more dynamic approach. Over the decade, GSK's cost of revenue decreased by about 28%, while Dyne's saw a dramatic 99% drop from its 2017 peak. This data not only underscores the contrasting strategies of these companies but also reflects broader industry trends in cost management and efficiency.
Cost of Revenue Comparison: Pfizer Inc. vs Dyne Therapeutics, Inc.
Cost Insights: Breaking Down GSK plc and Pharming Group N.V.'s Expenses
GSK plc vs Telix Pharmaceuticals Limited: Efficiency in Cost of Revenue Explored
GSK plc vs Ionis Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for GSK plc and ADMA Biologics, Inc.
Cost of Revenue Comparison: GSK plc vs CRISPR Therapeutics AG
Cost of Revenue Trends: GSK plc vs Wave Life Sciences Ltd.
Cost Insights: Breaking Down BeiGene, Ltd. and Dyne Therapeutics, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Incyte Corporation vs Dyne Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Corcept Therapeutics Incorporated vs Dyne Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Wave Life Sciences Ltd. vs Dyne Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Celldex Therapeutics, Inc. vs Dyne Therapeutics, Inc.